Our primary focus is developing Molecular Platform-based Regenerative Medicine to repair and regenerate damaged tissues from diseases and make them available in RNA or peptide therapeutics by activating endogenous stem cells.
We believe our signature technology, the Wake-up Stem Cell system, will deliver hope for a cure to patients suffering from incurable diseases and innovative technology to the global healthcare industry.
RegenInnopharm Inc.(Subsidiary of Catholic Technology Holding Company, since 2020)